Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 113.02 +1.36 (+1.22%) Official Closing Price Updated: 4:10 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 874,207 Open 111.65 Bid (Size) 109.09 (1) Ask (Size) 116.76 (1) Prev. Close 111.66 Today's Range 110.25 - 113.21 52wk Range 59.22 - 116.25 Shares Outstanding 50,367,507 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock June 14, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in Upcoming Investor Conferences May 28, 2024 From Glaukos Corporation Via Business Wire Performance YTD +46.63% +46.63% 1 Month +4.14% +4.14% 3 Month +29.14% +29.14% 6 Month +32.79% +32.79% 1 Year +74.12% +74.12% More News Read More Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings) May 22, 2024 Via Benzinga Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst May 02, 2024 Via Benzinga Topics Earnings Exposures Financial Analyst Ratings For Glaukos April 08, 2024 Via Benzinga 5 Analysts Have This To Say About Glaukos March 22, 2024 Via Benzinga Glaukos: Q4 Earnings Insights February 21, 2024 Via Benzinga C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday May 02, 2024 Via Benzinga GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024 May 01, 2024 Via InvestorPlace Glaukos Announces First Quarter 2024 Financial Results May 01, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces the Release of its 2023 Sustainability Report April 16, 2024 From Glaukos Corporation Via Business Wire Earnings Scheduled For February 21, 2024 February 21, 2024 Via Benzinga Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 April 10, 2024 From Glaukos Corporation Via Business Wire Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday April 03, 2024 Via Benzinga Topics Stocks Exposures US Equities Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant) April 03, 2024 From Glaukos Corporation Via Business Wire Analyst Ratings For Glaukos February 16, 2024 Via Benzinga Unveiling 7 Analyst Insights On Glaukos December 21, 2023 Via Benzinga Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting April 01, 2024 From Glaukos Corporation Via Business Wire Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday February 22, 2024 Via Benzinga Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results February 21, 2024 From Glaukos Corporation Via Business Wire Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21 January 31, 2024 From Glaukos Corporation Via Business Wire Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance January 09, 2024 From Glaukos Corporation Via Business Wire Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst December 21, 2023 Via Benzinga Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday December 21, 2023 Via Benzinga Glaukos Announces Participation in the J.P. Morgan Healthcare Conference December 20, 2023 From Glaukos Corporation Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
